Daily FNArena News - Australia

All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest

Previous Stories

Ventracor Not Impacted By US Reimbursement Changes

Apr 20 2006

Panic selling seems to have been absent following proposed medical reimbursement changes in the US. ABN Amro Morgans says this is how it should be, because Ventracor won’t be impacted.


Value Plays Remain Despite Record Market Levels

Apr 20 2006

ABN Amro’s value favourites are not necessarily those of other experts in the market, and vice versa.


Site Visits Reinforce Positive Views on Perseverance, Bendigo

Apr 19 2006

Tolhurst Noall went fossicking in Victoria and came away happy.


Austal Scores A Sixty Percent Target Revision

Apr 19 2006

After reviewing Austal’s first half performance, UBS seems to have had an epiphany.


ABN Amro Provides Big Boost To WorleyParsons

Apr 19 2006

ABN Amro believes there’s fair value in the shares up to $26 a piece.


Resonance Health Makes Strides In Liver Testing

Apr 18 2006

From the biotech desk: Resonance has announced Canadian approval for its liver iron concentration test.


Nuenco and Salinas Scoring Positive Results In Californian Oil

Apr 18 2006

ASX-listed oil explorers anticipate significant value as positive results flow in from their Californian well.


Orica Preferred To Dyno Nobel

Apr 18 2006

Two specialists have already weighed up Dyno Nobel against Orica. The latter seems a clear winner.


ABN Amro Remains Neutral on Australia’s Banking Sector

Apr 18 2006

Brokers analyse the banking sector ahead of the upcoming results, with solid results expected.


Second Half Rate Rise Speculation Growing

Apr 13 2006

There is little support among economists for a rate rise before the end of the financial year, but now UBS joins the school tipping a hike before the end of calendar 2006.



Analyse The Market From A Different Angle